Outcomes of extracorporeal membrane oxygenation support in pediatric hemato-oncology patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: In this study, we reviewed the outcomes of pediatric patients with malignancies who underwent hematopoietic stem cell transplantation (HSCT) and extracorporeal membrane oxygenation (ECMO).Methods: We retrospectively analyzed the records of pediatric hemato-oncology patients treated with chemotherapy or HSCT and who received ECMO in the pediatric intensive care unit (PICU) at Seoul National University Children’s Hospital from January 2012 to December 2020.Results: Over a 9-year period, 21 patients (14 males and 7 females) received ECMO at a single pediatric institute; 10 patients (48%) received veno-arterial (VA) ECMO for septic shock (n=5), acute respiratory distress syndrome (ARDS) (n=3), stress-induced myopathy (n=1), or hepatopulmonary syndrome (n=1); and 11 patients (52%) received veno-venous (VV) ECMO for ARDS due to pneumocystis pneumonia (n=1), air leak (n=3), influenza (n=1), pulmonary hemorrhage (n=1), or unknown etiology (n=5). All patients received chemotherapy; 9 received anthracycline drugs and 14 (67%) underwent HSCT. Thirteen patients (62%) were diagnosed with malignancies and 8 (38%) were diagnosed with non-malignant disease. Among the 21 patients, 6 (29%) survived ECMO in the PICU and 5 (24%) survived to hospital discharge. Among patients treated for septic shock, 3 of 5 patients (60%) who underwent ECMO and 5 of 10 patients (50%) who underwent VA ECMO survived. However, all the patients who underwent VA ECMO or VV ECMO for ARDS died. Conclusions: ECMO is a feasible treatment option for respiratory or heart failure in pediatric patients receiving chemotherapy or undergoing HSCT.
Abstract
Background: In this study, we reviewed the outcomes of pediatric patients with malignancies who underwent hematopoietic stem cell transplantation (HSCT) and extracorporeal membrane oxygenation (ECMO).Methods: We retrospectively analyzed the records of pediatric hemato-oncology patients treated with chemotherapy or HSCT and who received ECMO in the pediatric intensive care unit (PICU) at Seoul National University Children’s Hospital from January 2012 to December 2020.Results: Over a 9-year period, 21 patients (14 males and 7 females) received ECMO at a single pediatric institute; 10 patients (48%) received veno-arterial (VA) ECMO for septic shock (n=5), acute respiratory distress syndrome (ARDS) (n=3), stress-induced myopathy (n=1), or hepatopulmonary syndrome (n=1); and 11 patients (52%) received veno-venous (VV) ECMO for ARDS due to pneumocystis pneumonia (n=1), air leak (n=3), influenza (n=1), pulmonary hemorrhage (n=1), or unknown etiology (n=5). All patients received chemotherapy; 9 received anthracycline drugs and 14 (67%) underwent HSCT. Thirteen patients (62%) were diagnosed with malignancies and 8 (38%) were diagnosed with non-malignant disease. Among the 21 patients, 6 (29%) survived ECMO in the PICU and 5 (24%) survived to hospital discharge. Among patients treated for septic shock, 3 of 5 patients (60%) who underwent ECMO and 5 of 10 patients (50%) who underwent VA ECMO survived. However, all the patients who underwent VA ECMO or VV ECMO for ARDS died. Conclusions: ECMO is a feasible treatment option for respiratory or heart failure in pediatric patients receiving chemotherapy or undergoing HSCT.
참고문헌 (23)
- Zabrocki LA, "Extracorporeal membrane oxygenation for pediatric respiratory failure : survival and predictors of mortality", Crit Care Med, 39, pp.364~370 (2011)
- von Bahr V, "Long-term survival and causes of late death in children treated with extracorporeal membrane oxygenation", Pediatr Crit Care Med, 18, pp.272~280 (2017)
- Jenks CL, "Pediatric extracorporeal membrane oxygenation", Crit Care Clin, 33, pp.825~841 (2017)
- Coleman RD, "Extracorporeal membrane oxygenation mortality in high-risk populations : an analysis of the pediatric health information system database", ASAIO J, 66, pp.327~331 (2020)
- Slooff V, "Role of extracorporeal membrane oxygenation in pediatric cancer patients : a systematic review and meta-analysis of observational studies", Ann Intensive Care, 12, pp.8~ (2022)
- Gupta M, "Extracorporeal life support for severe respiratory failure in children with immune compromised conditions", Pediatr Crit Care Med, 9, pp.380~385 (2008)
- Gow KW, "Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure : the extracorporeal life support experience", Crit Care Med, 37, pp.1308~1316 (2009)
- Leahey AM, "Successful use of extracorporeal membrane oxygenation(ECMO)during BMT for SCID", Bone Marrow Transplant, 21, pp.839~840 (1998)
- Fan K, "Case report : management approach and use of extracorporeal membrane oxygenation for diffuse alveolar hemorrhage after pediatric hematopoietic cell transplant", Front Pediatr, 8, pp.587601~ (2020)
- Kebudi R, "Prolonged extracorporeal membrane oxygenation in pediatric leukemia with severe acute respiratory distress syndrome and persistent fungemia", Pediatr Blood Cancer, 68, pp.e28966~ (2021)
- Prabhu AD, "Extracorporeal life support in the acute management of tumour lysis syndrome", Interact Cardiovasc Thorac Surg, 15, pp.568~569 (2012)
- Olson TL, "Improving outcomes for children requiring extracorporeal membrane oxygenation therapy following hematopoietic stem cell transplantation", Crit Care Med, 49, pp.e381~e393 (2021)
- Suzuki Y, "Extracorporeal membrane oxygenation for pediatric patients with malignancy : outcomes and trends in the last decade", J Am Coll Surg, 233, pp.S293~S294 (2021)
- Potratz JC, "Extracorporeal membrane oxygenation in children with cancer or hematopoietic cell transplantation : single-center experience in 20 consecutive patients", Front Oncol, 11, pp.664928~ (2021)
- Ranta S, "Extracorporeal membrane oxygenation support in children with hematologic malignancies in Sweden", J Pediatr Hematol Oncol, 43, pp.e272~e275 (2021)
- Cortina G, "Extracorporeal membrane oxygenation offers long-term survival in childhood leukemia and acute respiratory failure", Crit Care, 22, pp.222~ (2018)
- Steppan DA, "Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation : the PEDECOR experience", Pediatr Blood Cancer, 67, pp.e28403~ (2020)
- Kang HS, "Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies", Korean J Intern Med, 30, pp.478~488 (2015)
- Di Nardo M, "Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy : an international and multidisciplinary consensus statement", Lancet Child Adolesc Health, 6, pp.116~128 (2022)
- Di Nardo M, "Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation : an international expert statement", Lancet Respir Med, 11, pp.477~492 (2023)
- Smith S, "Long-term survival after extracorporeal life support in children with neutropenic sepsis", Intensive Care Med, 42, pp.942~943 (2016)
- Di Nardo M, "Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation : an updated analysis of the Extracorporeal Life Support Organization experience", Intensive Care Med, 40, pp.754~756 (2014)
- Gow KW, "Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation : the Extracorporeal Life Support Organization experience", J Pediatr Surg, 41, pp.662~667 (2006)